ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för chs-828. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

14 träffar

Bibliografisk träff 2024-04-05

Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.

Velma GR, Krider IS, Alves ETM, Courey JM, Laham MS, Thatcher GRJ.

J Med Chem · research support, non-u.s. gov't; review-article; review; journal article; research support, n.i.h., extramural · DOI 10.1021/acs.jmedchem.3c02112

Bibliografisk träff 2022-05-06

Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs.

Elattar KM, El-Khateeb AY, Hamed SE.

RSC Med Chem · review-article; review; journal article · DOI 10.1039/d2md00076h

Bibliografisk träff 2021-09-23

Recent contributions of quinolines to antimalarial and anticancer drug discovery research.

Van de Walle T, Cools L, Mangelinckx S, D'hooghe M.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2021.113865

Bibliografisk träff 2019-08-01

Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group.

Travelli C, Aprile S, Mattoteia D, Colombo G, Clemente N, Scanziani E, Terrazzino S, Alisi MA, Polenzani L, Grosa G, Genazzani AA, Tron GC, Galli U.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2019.111576

Bibliografisk träff 2017-06-14

SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT).

Curtin ML, Heyman HR, Clark RF, Sorensen BK, Doherty GA, Hansen TM, Frey RR, Sarris KA, Aguirre AL, Shrestha A, Tu N, Woller K, Pliushchev MA, Sweis RF, Cheng M, Wilsbacher JL, Kovar PJ, Guo J, Cheng D, Longenecker KL, Raich D, Korepanova AV, Soni NB, Algire MA, Richardson PL, Marin VL, Badagnani I, Vasudevan A, Buchanan FG, Maag D, Chiang GG, Tse C, Michaelides MR.

Bioorg Med Chem Lett · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1016/j.bmcl.2017.06.018

Bibliografisk träff 2016-08-30

Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors.

Zak M, Yuen PW, Liu X, Patel S, Sampath D, Oeh J, Liederer BM, Wang W, O'Brien T, Xiao Y, Skelton N, Hua R, Sodhi J, Wang Y, Zhang L, Zhao G, Zheng X, Ho YC, Bair KW, Dragovich PS.

J Med Chem · journal article · DOI 10.1021/acs.jmedchem.6b00697

Bibliografisk träff 2014-08-15

Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.

Kamel MM, Megally Abdo NY.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2014.08.047

Bibliografisk träff 2014-01-22

Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).

Giannetti AM, Zheng X, Skelton NJ, Wang W, Bravo BJ, Bair KW, Baumeister T, Cheng E, Crocker L, Feng Y, Gunzner-Toste J, Ho YC, Hua R, Liederer BM, Liu Y, Ma X, O'Brien T, Oeh J, Sampath D, Shen Y, Wang C, Wang L, Wu H, Xiao Y, Yuen PW, Zak M, Zhao G, Zhao Q, Dragovich PS.

J Med Chem · journal article · DOI 10.1021/jm4015108

Bibliografisk träff 2013-11-13

Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.

Christensen MK, Erichsen KD, Olesen UH, Tjørnelund J, Fristrup P, Thougaard A, Nielsen SJ, Sehested M, Jensen PB, Loza E, Kalvinsh I, Garten A, Kiess W, Björkling F.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm4009949

Bibliografisk träff 2013-07-31

Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors.

Zheng X, Bauer P, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Han B, Ho YC, Kley N, Lin J, Reynolds DJ, Sharma G, Smith CC, Wang Z, Dragovich PS, Gunzner-Toste J, Liederer BM, Ly J, O'Brien T, Oh A, Wang L, Wang W, Xiao Y, Zak M, Zhao G, Yuen PW, Bair KW.

J Med Chem · journal article · DOI 10.1021/jm4008664

Bibliografisk träff 2013-06-13

Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors.

Zheng X, Bauer P, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Han B, Ho YC, Kley N, Lin J, Reynolds DJ, Sharma G, Smith CC, Wang Z, Dragovich PS, Oh A, Wang W, Zak M, Gunzner-Toste J, Zhao G, Yuen PW, Bair KW.

J Med Chem · journal article · DOI 10.1021/jm400186h

Bibliografisk träff 2013-05-31

Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.

Galli U, Travelli C, Massarotti A, Fakhfouri G, Rahimian R, Tron GC, Genazzani AA.

J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1021/jm4001049

Bibliografisk träff 2005-05-01

EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828.

Binderup E, Björkling F, Hjarnaa PV, Latini S, Baltzer B, Carlsen M, Binderup L.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2005.03.064

Bibliografisk träff 2004-03-01

Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives.

Chern JH, Shia KS, Chang CM, Lee CC, Lee YC, Tai CL, Lin YT, Chang CS, Tseng HY.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2003.12.073